Skip to main content
. Author manuscript; available in PMC: 2022 Feb 9.
Published in final edited form as: Expert Rev Vaccines. 2017 Dec 29;17(2):145–161. doi: 10.1080/14760584.2018.1418665

Figure 4. Rotavirus vaccine IgA seroconversion with and without OPV concurrently.

Figure 4.

Abbreviations: SC: seroconversion, RV1: Rotarix, RV5: Rotateq † Statistically significant (p < 0.05); 1[75,106-113]; 22 doses at 6 and 10 weeks of age; 32 doses at 10 and 14 weeks of age; World Bank list of economies (December 2016) low-income (L); lower middle-income (LM); upper middle-income (UM); high-income (H).